|
May 09, 2012, 07.00 PM IST
Ranbaxy Laboratories and Glenmark Pharma may give opportunities on the long side,says Shardul Kulkarni of Angel Broking
Ranbaxy Laboratories and Glenmark Pharma may give opportunities on the long side,says Shardul Kulkarni of Angel Broking
Kulkarni told CNBC-TV18, "ITC, TCS were major contributors in yesterdays fall, in which stocks fell over 5% each. Day before that the market recovered, but it recovered wherein the FIIs went short on the market to the tube of around Rs 1500 crore cash+F&O combined." He further added. "So, individual stocks may give opportunities, but I would not take a call on the Nifty as of now. In the phama space, Ranbaxy Laboratories, Glenmark both the stocks may give you opportunities on the long side."
Set email alert for |
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
